Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT01977274 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Predictive Clinical and Biological Parameters in Gynecological Cancer

Study acronym: GC-BIO
StatusActive, Not Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 2023 to Dec 2033
    • Trial status: Recruiting to Active, Not Recruiting
    • Study completion date: Dec 2033 to Dec 2035
    • Site details revised
    v5
  2. Primary completion date: Dec 2018 to Dec 2023
    • Study completion date: Dec 2028 to Dec 2033
    • Site contact updated
    • Study title shortened, about 3 words
    v4
  3. Eligibility criteria expanded, about 17 words
    • Site contact updated
    v3
  4. Trial status: Not Yet Recruiting to Recruiting
    • Site details revised
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Research of predictive clinical and biological factors in breast cancer : genomic, proteomic, mutation
Trial Details
NCT Number NCT01977274
Lead Sponsor Institut Paoli-Calmettes
Conditions
(from sponsor)		 Ovarian Cancer, Endometrium Cancer, Cervix Cancer
Related terms Endometrial Neoplasms, Ovarian Neoplasms, Uterine Cervical Neoplasms
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov